Expression of Fas (CD95) ligand is correlated with IL-10 and granulocyte colony-stimulating factor expression in oral and oropharyngeal squamous cell carcinoma

被引：13
|
作者：
Fujieda, S [1 ]
Sunaga, H [1 ]
Tsuzuki, H [1 ]
Fan, GK [1 ]
Ito, T [1 ]
Sugimoto, C [1 ]
Saito, H [1 ]
机构：
[1] Fukui Med Univ, Dept Otorhinolaryngol, Fukui 9101193, Japan
来源：
CANCER LETTERS | 2000年 / 161卷 / 01期
关键词：
Fas; Fas ligand; IL-10; granulocyte colony-stimulating factor; oral; oropharyngeal;
D O I：
10.1016/S0304-3835(00)00599-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The Fas/Fas ligand (FasL) pathway has been shown to be an important cellular pathway mediating apoptosis. In this study we investigated the expression of Fas and FasL and the rate of spontaneous apoptosis in 58 oral and oropharyngeal squamous cell carcinoma (SCC) by using immunohistochemical techniques. There was no correlation between Fas or FasL expression and clinicopathological factors. The expression of Fas in the tumor did not affect spontaneous apoptosis of the tumor cells. However, FasL expression was associated with IL-10 and granulocyte colony-stimulating factor expression in oral and oropharyngeal SCC. These results suggested that the Fas/FasL system is connected with the expression of various factors including cytokines in tumor cells. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：73 / 81
页数：9
相关论文
共 50 条
  • [1] Granulocyte Colony-stimulating Factor Producing Oropharyngeal Squamous Cell Carcinoma
    Schurmann, Gregory
    Zweifel, Martin
    Giger, Roland
    Rau, Tilman T.
    Vinzens, Sarah
    Dettmer, Matthias S.
    Kurian, Yojena
    IN VIVO, 2021, 35 (03): : 1785 - 1790
  • [2] Fas receptor (CD95) & Fas ligand (CD 178) expression in patients with tobacco-related intraoral squamous cell carcinoma
    Das, Satya N.
    Khare, Pratima
    Singh, Manoj K.
    Sharma, Suresh C.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 134 (01) : 54 - 60
  • [3] Expression of granulocyte colony-stimulating factor receptor correlates with prognosis in oral and mesopharyngeal carcinoma
    Tsuzuki, H
    Fujieda, S
    Sunaga, H
    Noda, I
    Saito, H
    CANCER RESEARCH, 1998, 58 (04) : 794 - 800
  • [4] Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10
    Barreiro, R
    Luker, G
    Herndon, J
    Ferguson, TA
    JOURNAL OF IMMUNOLOGY, 2004, 173 (03): : 1519 - 1525
  • [5] Squamous Cell Carcinoma of the Urachus Producing Granulocyte Colony-Stimulating Factor
    Kuramoto, Tomomi
    Kikkawa, Kazuro
    Nishihata, Masaya
    Matsumura, Nagahide
    Kohjimoto, Yasuo
    Inagaki, Takeshi
    Uekado, Yasunari
    Hara, Isao
    UROLOGY, 2009, 73 (02) : 442.e5 - 442.e7
  • [6] Squamous cell carcinoma of the cervix producing granulocyte colony-stimulating factor
    Nasu, K
    Inoue, C
    Takai, N
    Kashima, K
    Miyakawa, I
    OBSTETRICS AND GYNECOLOGY, 2004, 104 (05): : 1086 - 1088
  • [7] Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder
    Tachibana, M
    Miyakawa, A
    Uchida, A
    Murai, M
    Eguchi, K
    Nakamura, K
    Kubo, A
    Hata, JI
    BRITISH JOURNAL OF CANCER, 1997, 75 (10) : 1489 - 1496
  • [8] Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder
    M Tachibana
    A Miyakawa
    A Uchida
    M Murai
    K Eguchi
    K Nakamura
    A Kubo
    J-I Hata
    British Journal of Cancer, 1997, 75 : 1489 - 1496
  • [9] Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions
    Sunaga, H
    Fujieda, S
    Tsuzuki, H
    Asamoto, K
    Fukuda, M
    Saito, H
    ANTICANCER RESEARCH, 2001, 21 (4B) : 2901 - 2906
  • [10] EXPRESSION OF GRANULOCYTE COLONY-STIMULATING FACTOR BY HUMAN CELL-LINES
    DEVLIN, JJ
    DEVLIN, PE
    MYAMBO, K
    LILLY, MB
    RADO, TA
    WARREN, MK
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 41 (04) : 302 - 306
12345